The influence of polymorphism in methotrexate pathway genes on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis
Not Applicable
- Conditions
- Articular-type juvenile idiopathic arthritis (JIA)
- Registration Number
- JPRN-UMIN000002931
- Lead Sponsor
- Department of Pediatrics, Yokohama City University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
The patient who was judged by physicians as an improper case for enrollment in this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy and toxicity of methotrexate in patients with JIA
- Secondary Outcome Measures
Name Time Method Subgroup analysis based on (1)time interval between onset and treatment, (2)response to therapy, (3)the level of anti-citrullinated peptide antibodies, and rheumatoid factor.